Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

FACDX vs QAAGZX overlap: 47% of top holdings shared

Bottom line

How much do FACDX and QAAGZX overlap?

47% of their top holdings overlap by weight. 11 securities appear in both funds' top 25, making up 40.0% of FACDX's assets and 46.1% of QAAGZX's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

FACDXQAAGZX
Weight overlap (top 25)47%
Shared holdings11
Weight in shared holdings40.0%46.1%
Total positions154277
Expense ratio0.96%0.86%
Holdings as ofJul 31, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Holdings FACDX and QAAGZX have in common

Holding% of FACDX% of QAAGZXOverlap
ELI LILLY and CO7.66%14.06%7.66%
Danaher Corp6.75%1.44%1.44%
Thermo Fisher Scientific Inc6.31%2.53%2.53%
Unitedhealth Group Inc4.17%5.88%4.17%
JOHNSON and JOHNSON3.78%6.64%3.78%
Abbvie Inc3.62%5.12%3.62%
MERCK and CO INC2.09%4.00%2.09%
Natera Inc1.65%1.44%1.44%
Guardant Health Inc1.48%1.22%1.22%
Cvs Health Corp1.29%0.93%0.93%
Gilead Sciences Inc1.25%2.79%1.25%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in FACDX

  1. Fidelity Revere Street Trust — 2.54%
  2. Argenx Se — 2.09%
  3. West Pharmaceutical Svcs Inc — 2.06%
  4. Ascendis Pharma A/s — 1.95%
  5. Alnylam Pharmaceuticals Inc — 1.78%
  6. Agilent Technologies Inc — 1.75%
  7. Viatris Inc — 1.67%
  8. 10x Genomics Inc — 1.45%
  9. Revolution Medicines Inc — 1.44%
  10. Waters Corp — 1.43%
  11. Oruka Therapeutics Inc — 1.32%
  12. Ucb Sa — 1.32%
  13. Boston Scientific Corp — 1.23%
  14. Repligen Corp — 1.22%

Only in QAAGZX

  1. Vertex Pharmaceuticals Inc — 2.26%
  2. Bristol-myers Squibb Co — 2.12%
  3. Abbott Laboratories — 1.91%
  4. Intuitive Surgical Inc — 1.89%
  5. Amgen Inc — 1.80%
  6. Stryker Corp — 1.78%
  7. Elevance Health Inc — 1.54%
  8. Cardinal Health Inc — 1.04%
  9. Royalty Pharma Plc- Cl A — 0.97%
  10. Tenet Healthcare Corp — 0.94%
  11. Kymera Therapeutics Inc — 0.89%
  12. T. Rowe Price Government Reserve Fund — 0.87%
  13. Protagonist Therapeutics Inc — 0.85%
  14. Moderna Therapeutics Inc — 0.83%

Asset mix

Asset typeFACDXQAAGZX
Stocks97.7%96.9%
Cash & short-term funds2.8%0.9%
Preferred stock2.1%2.2%
Bonds0.2%0.1%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Country mix

CountryFACDXQAAGZX
US88.0%92.3%
NL2.9%1.0%
GB2.6%1.8%
DK2.0%0.7%
BE1.3%—
KY1.3%0.5%
BM1.0%0.7%
IE1.0%0.8%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do FACDX and QAAGZX overlap?
About 47% by weight. 11 securities appear in both funds' top 25 holdings; they make up 40.0% of FACDX's assets and 46.1% of QAAGZX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do FACDX and QAAGZX have in common?
The largest shared holdings are ELI LILLY and CO, Unitedhealth Group Inc, JOHNSON and JOHNSON, Abbvie Inc, Thermo Fisher Scientific Inc.
Should I own both FACDX and QAAGZX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, FACDX or QAAGZX?
QAAGZX is broader, with 277 positions versus 154 for FACDX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.